- Title: Subtitle
- PP01.118: Phase 1b/2 trial of BNT324/DB-1311 (B7H3 ADC) with Pumitamig (BNT327; PD-L1 x VEGF-A bsAb) in Lung Cancer (SCLC or NSCLC): BNT324-01 Trial in Progress
- Creators
- Adam Schoenfeld - Memorial Sloan Kettering Cancer CenterAlexander Spira - Virginia Cancer SpecialistsAaron E. Lisberg - UCLA, Los Angeles, CAMartin E. Gutierrez - John Theurer Cancer Center at Hackensack UMC, Hackensack, NJKamlesh Sankhala - Precision NextGen Oncology and Research Center, Beverly Hills, CAMargaret Byrne - University of IowaKaren L. Reckamp - Cedars-Sinai Medical CenterAngel Qin - U-M Rogel Cancer CenterThomas U. Marron - Icahn School of Medicine at Mount SinaiKartik Konduri - Texas Oncology DFW, Dallas, TXDonald A. Richards - Sarah Cannon Research InstituteJohn Paschold - Virginia Oncology AssociatesClifton Layman - NSF National eXtreme Ultrafast Science FacilityErin L. Schenk - The Medical Center of AuroraKaushal Parikh - Mayo ClinicYanyan Lou - Mayo Clinic in FloridaVinicius Ernani - Mayo Clinic in ArizonaAlex Adjei - Case Comprehensive Cancer CenterMehmet Altan - MD Anderson Cancer Center, Houston, TXYang Qiu - Duality Biologics, Shanghai, CHINAHannah Fang - Duality Biologics, Shanghai, CHINAHua Mu - Duality Biologics, Shanghai, CHINAMichael Pinho - BioNTech US Inc, Cambridge, MATroy Reed - BioNTech US Inc, Cambridge, MAMelisa Soland - BioNTech US Inc, Cambridge, MARaoul Tibes - BioNTech SE, Mainz, GERMANYÖzlem Türeci - BioNTech SE, Mainz, GERMANYUgur Sahin - BioNTech SE, Mainz, GERMANYLuis Paz-Ares - Hospital Universitario 12 De Octubre
- Resource Type
- Abstract
- Publication Details
- Journal of thoracic oncology, Vol.21(5), 103852
- DOI
- 10.1016/j.jtho.2026.103852
- ISSN
- 1556-0864
- Publisher
- Elsevier Inc
- Language
- English
- Date published
- 05/2026
- Academic Unit
- Internal Medicine
- Record Identifier
- 9985163700302771
Abstract
PP01.118: Phase 1b/2 trial of BNT324/DB-1311 (B7H3 ADC) with Pumitamig (BNT327; PD-L1 x VEGF-A bsAb) in Lung Cancer (SCLC or NSCLC): BNT324-01 Trial in Progress
Journal of thoracic oncology, Vol.21(5), 103852
05/2026
DOI: 10.1016/j.jtho.2026.103852
Details
Metrics
1 Record Views